NCT07853105
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07853105
Title Phase I/II Trial of Dinutuximab Beta in Combination With Irinotecan and Rapamycin in Pediatric, Adolescents and Adult Patients With Relapsed/Refractory Bone Tumors. (BONE DINIRRA)
Acronym BONE DINIRRA
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University Hospital, Strasbourg, France
Indications
Therapies
Age Groups: adult | child
Covered Countries FRA

Facility Status City State Zip Country Details
Oncologie Médicale-Institut Bergonié Bordeaux France Details
Unité d'Hémato-Oncologie Pédiatrique (UHOP) -CHU de Bordeaux - GH Pellegrin Bordeaux France Details
Oncologie - Unité pédiatrique Centre Oscar Lambret Lille 59000 France Details
Institut d'hématologie et d'oncologie Pédiatrique iHOPE Lyon France Details
Oncologie médicale adulte- Centre Léon Bérard Lyon France Details
Hématologie, Immunologie et Oncologie Pédiatrique (HIOP), CHU Timone Enfants, Marseille France Details
Onco-hématologie pédiatrique- CHRU NANCY-BRABOIS Nancy France Details
Oncologie Médicale - Institut Curie Paris France Details
Oncopédiatrie-SIREDO - Institut Curie Paris France Details
Oncologie médicale, Hôpitaux Universitaires de Strasbourg Strasbourg 67000 France Details
Onco-hématologie pédiatrique- Hôpitaux Universitaires de Strasbourg Strasbourg 67098 France Details
Unité d'Hématologie Immunologie Oncologie Pédiatrique, CHU Toulouse Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field